The endometrial cancer market space will experience significant growth during the forecast period of 2025--2034. The future is brighter for patients with endometrial cancer. Targeted agents and ...

Prescriptions for GLP-1 receptor agonists in cancer patients have increased despite lack of clinical guidance. The overall ...

NUTLEY, N.J., Nov. 3, 2025 /PRNewswire/ -- Eisai announced today the presentation of clinical research in gynecologic oncology during the International Gynecologic Cancer Society (IGCS) 2025 Annual ...

The global endometrial cancer market is on course for steady expansion, projected to reach nearly $39 billion by 2030. Growth ...

Endometrial Cancer is a cancer of the endometrium a lining of the uterus If diagnosed timely it is possible to treat it ...

Understanding the early signs of endometrial cancer coming back is important. Being aware, attending check-ups, and acting ...

The most common type of gynecologic cancer in the U.S. has been on the rise in recent years — and there’s no standard screening for it. Uterine cancer will affect about 66,200 women in 2023 in the U.S ...

Endometrial cancer, the most common uterine cancer, often begins with subtle symptoms like abnormal bleeding, which can be ...

Uterine cancer is the fourth most common cancer among women and the most common cancer of a woman's reproductive system. There are two major types of uterine cancer: Adenocarcinoma of the endometrium: ...

A new study found that women who used hair straightening products were more than twice as likely to develop uterine cancer Women who use hair-straightening chemicals are at higher risk for uterine ...

A recent study has found that Black women may be at a higher risk for uterine cancer because of harmful chemicals in some hair straightening products. These chemicals affect your body’s hormones.